r.molnar
TL2 · Kuopio
Contributes reviews on supplier material. Based in Kuopio.
Joined 26 June 2025 · last posted 1d
72 posts, newest first. Showing up to 150.
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #49 · Analytics › Method validation · 26 Jul 2026 · 11 likes Helpful, and easy to find again, which is half of what a good reply is.
-
Designing a personal experiment that could change your mind — one year on Replied, post #80 · Research Methods › N-of-1 designs · 24 Jul 2026 · 16 likes Regression to the mean explains a great many personal experiments. People start when things are at their worst, and things at their worst tend to improve. That is all I…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #50 · Practice › Administration · 19 Jul 2026 · 28 likes Pinching a fold is useful for lean tissue and unnecessary elsewhere. The point is to keep the needle out of muscle, and whether you need to depends on the site and on…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #39 · Access › Insurance & coverage · 18 Jul 2026 · 21 likes Post #35 describes the usual case. This is about the unusual one. A clinician's supporting letter that addresses the criteria explicitly is worth considerably more than…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #34 · Compounds › Repair & healing peptides · 16 Jul 2026 · 19 likes The practical version of absence of controlled human data is three sentences long. The rigorous version is three pages and reaches the same conclusion with the…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #99 · Compounds › Semaglutide · 12 Jul 2026 · 17 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #44 · Practice › Side effects · 11 Jul 2026 · 30 likes Post #42 describes the usual case. This is about the unusual one. Nothing in this subcategory is medical advice, and the specific cases where that matters most are the…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #40 · Research Methods › Statistics · 8 Jul 2026 · 26 likes Post #38 answers the question as asked. The question underneath it is different. Whatever the answer on Absence of evidence turns out to be, the method for getting…
-
Alcohol: what is documented and what is folklore Replied, post #85 · Practice › Interactions · 30 Jun 2026 · 7 likes The honest answer on alcohol is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter. Most people…
-
A structured critique template this community uses — a second dataset Replied, post #23 · Evidence › Study critique · 29 Jun 2026 · 26 likes Picking up post #20: that is the part I would want checked first. Where a critique rests on a subgroup, check whether the interaction was tested. A difference between…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #39 · Access › Insurance & coverage · 26 Jun 2026 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Insurance and replacement policies, compared Replied, post #42 · Sourcing › Logistics · 25 Jun 2026 · 27 likes Worth separating two things that post #40 runs together. Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country.…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #97 · Evidence › Journal club · 25 Jun 2026 · 12 likes An hour is enough for one paper read properly and not enough for two read partly. The temptation is always to add the second.
-
Request: tag synonyms surfaced in search Replied, post #3 · Meta › Feature requests · 19 Jun 2026 · 14 likes For anyone finding this later: the short answer on tag synonyms surfaced in search is that it depends on one thing, and the rest of the thread is people identifying…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #10 · Outcomes › Body composition · 8 Jun 2026 · 0 likes Neither method is capable of detecting the month-to-month changes that people report detecting month to month. Not the answer, but possibly the question that gets there.
-
Pooling trials with different estimands Replied, post #4 · Evidence › Meta-analyses · 2 Jun 2026 · 4 likes Everything in the opening post holds. The case it does not cover is the one I have. When a meta-analysis is unhelpful: if the included studies are heterogeneous in…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #7 · Practice › Storage & stability · 31 May 2026 · 2 likes For anyone finding this later: the short answer on reconstituted is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #33 · Practice › Administration · 27 May 2026 · 0 likes Where I part company with post #32, and it is a narrow parting. The version of Pinch that I was taught turned out to be a teaching simplification. Useful, and not true…
-
The best-written scientific paper you have read Replied, post #64 · Lounge › Off topic · 25 May 2026 · 23 likes Paper, same. I think it is that writing by hand is slow enough to make you decide what is worth recording.
-
Coming back to: Measurement error in a self-reported exposure Replied, post #16 · Evidence › Study critique · 25 Apr 2026 · 0 likes Worth separating two things that post #15 runs together. Per-protocol and intention-to-treat analyses answer different questions and neither is the honest one by…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #111 · Pharmacology › Pharmacokinetics · 19 Apr 2026 · 11 likes Confirming post #108 from a second method, which matters more than confirming it from a second person. Volume of distribution: the theoretical volume the drug…
-
Follow-up: Sleep quality changes during weight loss Replied, post #7 · Wellbeing › Sleep · 19 Apr 2026 · 0 likes Confirming post #6 from a second method, which matters more than confirming it from a second person. Sleep-disordered breathing improving with weight reduction is one…
-
Spike-and-recover accuracy for a peptide assay Replied, post #25 · Analytics › Method validation · 7 Apr 2026 · 16 likes The arithmetic on spike-and-recover accuracy is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #24 · Practice › Administration · 7 Apr 2026 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #29 · Evidence › Trials · 2 Apr 2026 · 3 likes Post #28 is right about the mechanism and I think understates the practical bit. Marking my uncertainty on Subgroup analyses explicitly. I am confident about the…
-
How to ask about something you suspect is a bad idea Replied, post #71 · Start Here › How to Ask · 31 Mar 2026 · 0 likes This follows post #70 rather than contradicting it. Timeline questions need the timeline. Dates, in order, with what happened on each. "A while ago" and "recently" are…
-
Which fields on a certificate actually matter, ranked Replied, post #21 · Analytics › COA interpretation · 17 Mar 2026 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
-
Waist circumference technique and its repeatability Replied, post #50 · Outcomes › Progress reports · 11 Feb 2026 · 16 likes A single scale used throughout beats a more accurate scale introduced halfway through. Consistency beats accuracy for a trend. I would want to see it done twice before…
-
Request: a diff view for wiki revisions — the long version Replied, post #103 · Meta › Feature requests · 22 Jan 2026 · 1 like On post #101 — agreed on the reasoning, with one qualification. A definition problem is doing most of the work in this diff view for wiki revisions discussion. Once the…
-
Oral semaglutide bioavailability and its variability between people Replied, post #28 · Compounds › Oral incretins · 16 Jan 2026 · 2 likes The absorption enhancer in the licensed oral product works by transiently raising local gastric pH and promoting absorption across the mucosa. It is the reason the…
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #8 · Compounds › Secretagogues & GH axis · 15 Jan 2026 · 7 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #32 · Sourcing › Red flags · 30 Dec 2025 · 12 likes I had written a reply contradicting post #30 and deleted it. Here is what survived. Taking supplier seriously for a moment rather than deflecting: the honest position…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #91 · Practice › Side effects · 29 Dec 2025 · 7 likes That is consistent with mine, for whatever one more account is worth.
-
Tracking a preprint to publication: a worked example Replied, post #41 · Evidence › Preprints · 4 Dec 2025 · 3 likes Everything in post #39 holds. The case it does not cover is the one I have. Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #16 · Safety › Contraindications · 2 Dec 2025 · 10 likes Post #14 and I disagree about the size of the effect, not about the direction. Severe hepatic impairment: less is known than for kidney disease. Extreme caution or…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #46 · Compounds › Other compounds · 24 Nov 2025 · 1 like Answering the question post #44 raises rather than the one it answers. Several compounds discussed here have no published human pharmacokinetics at all. That means…
-
Thyroid function tests during substantial weight change Replied, post #128 · Clinical › Bloodwork · 9 Nov 2025 · 32 likes Adding the measurement that post #126 says would settle it. Rate of change is frequently more informative than absolute value, and it is only available if the earlier…
-
Payment mechanics and the recovery options that do not exist Replied, post #89 · Sourcing › Payments · 22 Oct 2025 · 8 likes Order confirmations that state the lot to be shipped are rare and are the single most useful thing a supplier can put on one.
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #34 · Analytics › Method validation · 22 Oct 2025 · 0 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
The headache that turns out to be dehydration Replied, post #28 · Nutrition & Training › Hydration & electrolytes · 19 Oct 2025 · 27 likes Where a laboratory result exists, quoting it with the reference interval makes the discussion tractable. Without it the thread is guesswork.
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #9 · Start Here › How to Ask · 19 Oct 2025 · 13 likes If your question has a deadline — a parcel in transit, a delivery you have to accept or refuse — say so. People answer differently when there is a clock on it.
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #20 · Sourcing › Regulatory · 28 Sep 2025 · 3 likes On post #16 — agreed on the reasoning, with one qualification. Compound being unapproved is one of those subjects where the general answer and the answer for a specific…
-
What a purity-only report leaves out Replied, post #27 · Sourcing › Independent verification · 27 Sep 2025 · 22 likes Taking post #26 at face value and following it one step further. Where the purity-only discussion usually stalls is that nobody wants to say "I do not know" and…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #32 · Compounds › Other compounds · 31 Aug 2025 · 4 likes The failure mode on catalogue breadth is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get…
-
Revisiting: List price versus negotiated price versus what you pay Replied, post #26 · Access › Pricing · 10 Aug 2025 · 16 likes Source for the List price versus negotiated price figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating…
-
Risk-of-bias tools and the judgement they conceal Replied, post #6 · Evidence › Meta-analyses · 27 Jun 2025 · 25 likes Post #5 is right about the mechanism and I think understates the practical bit. Double extraction with disagreement resolution is standard and is worth checking for,…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #139 · Access › Insurance & coverage · 16 Jun 2025 · 1 like Post #138 is right about the mechanism and I think understates the practical bit. Formulary status: the list of covered medications and the tier (how much you pay) they…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #21 · Data & Tools › Calculators · 9 Jun 2025 · 0 likes Significant figures in the output should not exceed what the inputs support. A concentration calculated from a nominal vial mass is not known to four decimal places.…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #18 · Pharmacology › Pharmacokinetics · 28 May 2025 · 2 likes Half-life determines how quickly concentration approaches steady state and does not determine what the steady-state concentration is. Dose and clearance determine that.…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #128 · Sourcing › Independent verification · 21 May 2025 · 5 likes The documentation on Janoshik is better than this thread and I say that as someone who has posted in the thread.
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #8 · Compounds › Secretagogues & GH axis · 20 May 2025 · 5 likes Post #6 describes the usual case. This is about the unusual one. Reading a rodent study sits at the boundary between what this community can usefully discuss and what…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #147 · Sourcing › Regulatory · 8 May 2025 · 1 like A label change is a regulatory event with a date and a document. Citing the document is what makes a claim about labelling checkable.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #72 · Compounds › Tirzepatide · 29 Apr 2025 · 0 likes Where I part company with post #68, and it is a narrow parting. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #38 · Clinical › Comorbidities · 20 Mar 2025 · 9 likes Posting my obstructive sleep apnoea numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #110 · Access › International · 19 Mar 2025 · 0 likes Post #108 is right about the mechanism and I think understates the practical bit. Regional practice around what a pharmacy will and will not do varies enormously and is…
-
Charge states for a 4 kDa peptide, worked through Replied, post #121 · Analytics › Mass spectrometry · 16 Mar 2025 · 14 likes What I want from this charge states thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
Titrating on tolerability rather than on the calendar — the long version Replied, post #3 · Practice › Dosing & titration · 7 Mar 2025 · 29 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Talking to a therapist about this specifically — does this still hold? Replied, post #14 · Wellbeing › Mental health · 7 Feb 2025 · 16 likes Where I part company with post #10, and it is a narrow parting. Motivation and expectation: starting with clear motivation and realistic expectations about what will…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #13 · Compounds › Other compounds · 16 Jan 2025 · 3 likes Building on post #10 rather than restating it. For any compound without a widely available reference standard, retention-time comparisons across laboratories are close…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #75 · Evidence › Journal club · 29 Dec 2024 · 11 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Escalating every six weeks instead of four: what I observed over eight months Started this topic · Practice › Dosing & titration · 28 Dec 2024 · 2 likes Escalating every six weeks instead of four: what I observed over eight months Writing it up because I had to work it out twice and would rather nobody else did. Asking…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #44 · Compounds › Semaglutide · 26 Dec 2024 · 4 likes Post #43 describes the usual case. This is about the unusual one. A methods point on Semaglutide formulation rather than a substantive one: if the comparison is not…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #15 · Compounds › Semaglutide · 19 Dec 2024 · 0 likes I had written a reply contradicting post #14 and deleted it. Here is what survived. What I can speak to on Molecular mass of semaglutide is narrow, so I will keep it…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #10 · Compounds › Semaglutide · 18 Dec 2024 · 0 likes I had written a reply contradicting post #7 and deleted it. Here is what survived. A methods point on Molecular mass of semaglutide rather than a substantive one: if…
-
Body image changing more slowly than the body Replied, post #5 · Wellbeing › Mental health · 10 Dec 2024 · 19 likes I read post #3 twice before replying, because I had assumed the opposite. Where a member is finding this hard, the useful reply is usually a question rather than an…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #4 · Access › Insurance & coverage · 24 Oct 2024 · 0 likes Speaking only to Step therapy requirements as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread…
-
US compounding rules and how they changed Replied, post #29 · Regional › North America · 18 Oct 2024 · 24 likes Where I part company with post #27, and it is a narrow parting. Where a compounding pathway existed and closed, posts describing it stay in the archive and should be…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #41 · Analytics › Mass spectrometry · 18 Aug 2024 · 6 likes I read post #40 twice before replying, because I had assumed the opposite. I have no financial interest in anything named in this thread and I want to say so before I…
-
Circumference measurements as a poor man's composition estimate Replied, post #32 · Outcomes › Body composition · 31 Jul 2024 · 3 likes Nothing here is medical advice and none of these measurements is diagnostic on its own. The general answer and the answer for your case may diverge here.
-
How to ask for a dose change without antagonising anyone Replied, post #9 · Clinical › Prescriber conversations · 28 Jul 2024 · 0 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. Noting that I have skin in this…
-
Guidelines revision: what changed and why Replied, post #68 · Meta › Announcements · 27 Jul 2024 · 0 likes Narrowing post #65, because the general version has more than one answer. Guidelines revision would be much easier to settle if anyone reported the denominator. Almost…
-
The mass-error checker and its intended scope Replied, post #18 · Data & Tools › Calculators · 29 May 2024 · 0 likes Coming back to post #16, because the follow-up matters more than the original answer. Two things can be true about mass-error checker at once: the mechanism is…